HOOKIPA Pharma IncNASDAQ:HOOKNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.8190
- TODAY'S CHANGE (%)0.0090 (1.1111%)
- Bid / Lots0.8102/ 5
- Ask / Lots0.8200/ 113
- Open / Previous Close0.8000 / 0.8100
- Day Range
- 52 Week Range
- Volume634,677
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HOOK |
|---|---|---|
| 09:32 ET | 2356 | 0.8133 |
| 09:34 ET | 100 | 0.8063 |
| 09:38 ET | 100 | 0.8001 |
| 09:41 ET | 1390 | 0.8001 |
| 09:45 ET | 1800 | 0.80505 |
| 09:50 ET | 400 | 0.8012 |
| 09:52 ET | 42209 | 0.80545 |
| 09:54 ET | 5000 | 0.80979 |
| 09:57 ET | 9071 | 0.805 |
| 09:59 ET | 3300 | 0.8002 |
| 10:01 ET | 100 | 0.805 |
| 10:03 ET | 300 | 0.8002 |
| 10:06 ET | 11392 | 0.80375 |
| 10:10 ET | 200 | 0.8036 |
| 10:12 ET | 3950 | 0.800101 |
| 10:14 ET | 100 | 0.8001 |
| 10:15 ET | 187 | 0.8001 |
| 10:19 ET | 1200 | 0.80495 |
| 10:21 ET | 4252 | 0.8088 |
| 10:24 ET | 5912 | 0.811401 |
| 10:26 ET | 250 | 0.8058 |
| 10:28 ET | 10135 | 0.8058 |
| 10:32 ET | 1257 | 0.8151 |
| 10:35 ET | 1500 | 0.8199 |
| 10:37 ET | 5099 | 0.8101 |
| 10:42 ET | 700 | 0.819 |
| 10:44 ET | 100 | 0.81505 |
| 10:50 ET | 100 | 0.81255 |
| 10:51 ET | 3800 | 0.81405 |
| 10:53 ET | 264 | 0.815 |
| 10:57 ET | 5255 | 0.8126 |
| 11:04 ET | 1100 | 0.81 |
| 11:06 ET | 3217 | 0.81 |
| 11:08 ET | 100 | 0.81 |
| 11:20 ET | 4300 | 0.81 |
| 11:24 ET | 500 | 0.81 |
| 11:27 ET | 96058 | 0.82155 |
| 11:29 ET | 1200 | 0.82155 |
| 11:31 ET | 365 | 0.820201 |
| 11:33 ET | 3100 | 0.822 |
| 11:36 ET | 17693 | 0.8201 |
| 11:44 ET | 1121 | 0.82155 |
| 11:45 ET | 70468 | 0.83201 |
| 11:47 ET | 7341 | 0.8455 |
| 11:49 ET | 1262 | 0.8391 |
| 11:54 ET | 1323 | 0.8375 |
| 11:56 ET | 485 | 0.830101 |
| 12:00 ET | 140 | 0.8302 |
| 12:02 ET | 4729 | 0.8333 |
| 12:03 ET | 100 | 0.83255 |
| 12:07 ET | 400 | 0.8301 |
| 12:09 ET | 27790 | 0.835 |
| 12:12 ET | 600 | 0.835 |
| 12:21 ET | 196 | 0.8302 |
| 12:23 ET | 2780 | 0.83097 |
| 12:25 ET | 100 | 0.833 |
| 12:30 ET | 1400 | 0.8333 |
| 12:36 ET | 250 | 0.8331 |
| 12:39 ET | 15848 | 0.833 |
| 12:45 ET | 10886 | 0.8307 |
| 12:48 ET | 12400 | 0.8305 |
| 12:52 ET | 92089 | 0.83 |
| 12:54 ET | 28319 | 0.8254 |
| 12:56 ET | 3100 | 0.814 |
| 12:59 ET | 774 | 0.8122 |
| 01:01 ET | 200 | 0.81615 |
| 01:03 ET | 100 | 0.81475 |
| 01:15 ET | 267 | 0.8147 |
| 01:24 ET | 100 | 0.81225 |
| 01:26 ET | 2472 | 0.8098 |
| 01:28 ET | 300 | 0.815 |
| 01:32 ET | 3800 | 0.801 |
| 01:35 ET | 100 | 0.813257 |
| 02:04 ET | 376 | 0.8072 |
| 02:06 ET | 3862 | 0.8011 |
| 02:13 ET | 1957 | 0.8019 |
| 02:20 ET | 100 | 0.8011 |
| 02:29 ET | 200 | 0.804325 |
| 02:36 ET | 5300 | 0.801 |
| 02:38 ET | 628 | 0.806 |
| 02:42 ET | 2100 | 0.8017 |
| 03:00 ET | 3100 | 0.8017 |
| 03:02 ET | 104 | 0.804 |
| 03:05 ET | 100 | 0.8055 |
| 03:07 ET | 14060 | 0.8023 |
| 03:09 ET | 250 | 0.801 |
| 03:12 ET | 475 | 0.80525 |
| 03:14 ET | 2200 | 0.8011 |
| 03:16 ET | 1000 | 0.801 |
| 03:21 ET | 100 | 0.801 |
| 03:23 ET | 1034 | 0.8086 |
| 03:32 ET | 2600 | 0.81 |
| 03:34 ET | 2500 | 0.8123 |
| 03:36 ET | 992 | 0.8179 |
| 03:38 ET | 700 | 0.81307 |
| 03:39 ET | 2100 | 0.813 |
| 03:41 ET | 1000 | 0.815 |
| 03:50 ET | 800 | 0.8133 |
| 03:56 ET | 447 | 0.8165 |
| 03:57 ET | 4194 | 0.8198 |
| 03:59 ET | 3241 | 0.819 |
Jun 5, 2024
DJ HOOKIPA Pharma Is Maintained at Buy by HC Wainwright & Co., from 7:49AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:49AM ET on Wednesday Jun 05, 2024 by Dow Jones
Jun 4, 2024
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting, from 1:00PM ET on Tuesday Jun 04, 2024 by Dow Jones
1:00PM ET on Tuesday Jun 04, 2024 by Dow Jones
May 30, 2024
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting, from 4:30PM ET on Thursday May 30, 2024 by Dow Jones
4:30PM ET on Thursday May 30, 2024 by Dow Jones
May 23, 2024
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting, from 5:01PM ET on Thursday May 23, 2024 by Dow Jones
5:01PM ET on Thursday May 23, 2024 by Dow Jones
May 21, 2024
DJ HOOKIPA Pharma Price Target Maintained With a $5.00/Share by RBC Capital, from 1:21PM ET on Tuesday May 21, 2024 by Dow Jones
1:21PM ET on Tuesday May 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
HOOKIPA Pharma Inc | 79.1M | 0.0x | --- |
Company Information
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
Contact Information
- Headquarters
- 350 Fifth Avenue, 72Nd Floor, Suite 7240NEW YORK, NY, United States 10118
- Phone
- ---
- Fax
- 302-655-5049
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $79.9M |
|---|---|
Revenue (TTM) | $53.6M |
Shares Outstanding | 99.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.84 |
EPS | $-0.59 |
Book Value | $0.91 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -119.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
